Walgreens Boots Alliance (WBA) Expected to Announce Earnings on Thursday

Walgreens Boots Alliance (NASDAQ:WBA) is expected to be issuing its quarterly earnings data before the market opens on Thursday, March 27th. Analysts expect the company to announce earnings of $0.53 per share and revenue of $37.90 billion for the quarter. Walgreens Boots Alliance has set its FY 2025 guidance at 1.400-1.800 EPS and its FY25 guidance at $1.40-$1.80 EPS.

Walgreens Boots Alliance (NASDAQ:WBA) last released its earnings results on Friday, January 10th. The pharmacy operator reported $0.51 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $0.38 by $0.13. The firm had revenue of $39.50 billion during the quarter, compared to analysts’ expectations of $37.40 billion. Walgreens Boots Alliance had a positive return on equity of 17.61% and a negative net margin of 5.87%. The company’s revenue was up 7.6% on a year-over-year basis. During the same quarter in the prior year, the company earned $0.66 EPS. On average, analysts expect Walgreens Boots Alliance to post $2 EPS for the current fiscal year and $1 EPS for the next fiscal year.

Walgreens Boots Alliance Stock Performance

Shares of Walgreens Boots Alliance stock opened at $11.12 on Wednesday. The company has a debt-to-equity ratio of 0.68, a current ratio of 0.64 and a quick ratio of 0.30. The firm has a market cap of $9.61 billion, a price-to-earnings ratio of -1.09, a price-to-earnings-growth ratio of 1.31 and a beta of 0.62. The stock’s 50-day moving average is $10.92 and its 200-day moving average is $9.87. Walgreens Boots Alliance has a one year low of $8.08 and a one year high of $22.05.

Analyst Ratings Changes

WBA has been the topic of several research reports. Truist Financial cut their target price on Walgreens Boots Alliance from $13.00 to $12.00 and set a “hold” rating on the stock in a research note on Friday, January 31st. Bank of America increased their target price on shares of Walgreens Boots Alliance from $7.50 to $8.50 and gave the stock an “underperform” rating in a report on Monday, January 13th. Wolfe Research upgraded shares of Walgreens Boots Alliance to a “hold” rating in a research note on Monday, February 24th. Deutsche Bank Aktiengesellschaft downgraded shares of Walgreens Boots Alliance from a “hold” rating to a “sell” rating and reduced their price objective for the stock from $11.00 to $9.00 in a research note on Friday, February 28th. Finally, Evercore ISI upped their target price on Walgreens Boots Alliance from $9.00 to $12.00 and gave the stock an “in-line” rating in a report on Monday, January 13th. Four research analysts have rated the stock with a sell rating, eight have issued a hold rating and two have given a buy rating to the company’s stock. Based on data from MarketBeat.com, Walgreens Boots Alliance presently has an average rating of “Hold” and a consensus target price of $10.59.

About Walgreens Boots Alliance

Walgreens Boots Alliance, Inc operates as a healthcare, pharmacy, and retail company in the United States, the United Kingdom, Germany, and internationally. It operates through three segments: U.S. Retail Pharmacy, International, and U.S. Healthcare. The U.S. Retail Pharmacy segment engages in operation of the retail drugstores, health and wellness services, specialty, and home delivery pharmacy services, which offers health and wellness, beauty, personal care and consumables, and general merchandise.